Your Daily Pharma Scoop: Abeona Presents Strong Data, Glaxo Nucala Treatment Benefit, Rocket Pharma’s Gene … – Seeking Alpha
|
Your Daily Pharma Scoop: Abeona Presents Strong Data, Glaxo Nucala Treatment Benefit, Rocket Pharma's Gene …
Seeking Alpha Abeona presented strong data from ABO-102 targeting MPS III A. Glaxo's asthma drug Nucala showed sustained treatment benefit in an open label study. Rocket Pharma's gene therapy drug RP-L102 showed treatment benefit in an early stage study in … |
